Immuron (IMRN) Invested Capital (2016 - 2025)
Immuron (IMRN) posted quarterly Invested Capital of $1.1 million for Q2 2025, down 30.41% year-over-year from $1.5 million in Q2 2024, and down 30.41% quarter-over-quarter from $1.5 million in Q2 2024.
Immuron (IMRN) Invested Capital (2016 - 2025) Analysis & Trends
Immuron's Invested Capital history runs 10 years deep, the most recent figure standing at $1.1 million for Q2 2025.
- In Q2 2025, Invested Capital fell 30.41% year-over-year to $1.1 million; the TTM figure through Sep 2025 stood at $1.1 million (down 30.41% YoY), while the FY2025 annual figure was $1.1 million, down 29.23% from the prior year.
- Invested Capital for Q2 2025 stood at $1.1 million, down from $1.5 million in the prior quarter.
- The five-year high for Invested Capital was $1.5 million in Q2 2024, with the low at $117827.7 in Q2 2021.
- The 5-year median for Invested Capital is $686734.4 (2022), against an average of $808941.3.
- The sharpest annual moves came in 2022 and 2025: Invested Capital jumped 482.83% in 2022, then slumped 30.41% in 2025.
- Immuron's Invested Capital stood at $117827.7 in 2021, then surged by 482.83% to $686734.4 in 2022, then declined by 3.86% to $660229.8 in 2023, then jumped by 130.41% to $1.5 million in 2024, then plunged by 30.41% to $1.1 million in 2025.
- Business Quant data shows IMRN's Invested Capital at $1.1 million in Q2 2025, $1.5 million in Q2 2024, and $660229.8 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Jun 30, 2023 | 660,229.84 |
| Jun 30, 2022 | 686,734.43 |
| Jun 30, 2021 | 117,827.68 |
| Jun 30, 2020 | 155,416.62 |
| Dec 31, 2019 | 98,120.00 |
| Jun 30, 2019 | 764,858.99 |
| Jun 30, 2018 | 521,845.23 |
| Dec 31, 2017 | 176,131.42 |
| Sep 28, 2017 | 178,246.74 |
| Aug 31, 2017 | 226,000.00 |
| Jun 30, 2017 | 996,527.08 |
| Dec 31, 2016 | 850,575.43 |